Engaging in conversation
On behalf of five pharmaceutical companies involved in the development of cell and gene therapies, the interest group HollandBIO, and the University of Groningen; we organised a stakeholder meeting about these therapies on Wednesday, September 16, 2020. The day consisted of a plenary opening, three workshops, and closing with a plenary debate where the workshops were discussed and focused on five propositions. An important aspect of this debate was that the stakeholders present were also able to bring their own views to the table to be heard.
Gaining new insights
More than 90 participants (incl. 30 online visitors) gathered at the Louwman Museum in The Hague. The wide range of stakeholders discussed perspectives for action on topics such as clinical research, regulations, reimbursement, and implementation in healthcare. The stakeholders included representatives from academic hospitals, pharmaceutical companies, patient associations, universities, biotech companies, medical specialists, and the Ministries of Health, Welfare & Sport and Education, Culture & Science.
This meeting provided the stakeholders with a better understanding of the positions and roles of the other stakeholders. Stakeholders gained insight into the bottlenecks and especially the action perspectives to properly prepare the Netherlands for this innovative form of medicine.
